The Food and Drug Administration warned Friday that high doses of the cholesterol-lowering drug Zocor may pose an elevated risk for muscle injury.
From the FDA warning:
Although muscle injury (called myopathy) is a known side effect with all statins, today’s warning highlights the greater risk of developing muscle injury, including rhabdomyolysis, for patients when they are prescribed and use higher doses of this drug. Rhabdomyolysis is the most serious form of myopathy and can lead to severe kidney damage, kidney failure, and sometimes death.
Here’s a related Los Angeles Times blog post.


